Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2313 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Karo Bio reports positive results from diabetes study

Karo Bio, a drug discovery and development company, has reported that compound KB3305, a liver selective antagonist for the glucocorticoid receptor, showed clinically relevant and statistically significant effects

Labopharm’s Phase III pain trial fails endpoint

Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm’s twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to

Cellumen launches new Alzheimer’s screening tool

Alzheimer’s Drug Discovery Foundation (ADDF) provided support for the development of novel tools for drug discovery applications, including cellular models of disease and biosensors that allow for sensitive

Sorin wins CE Mark for Esprit pacemaker

According to Sorin, the Esprit pacemaker, the latest family in the company’s pacemaker portfolio, is the world’s smallest pacemaker, at 8cc, with no compromise on longevity. Esprit includes